The SAGE Handbook of Drug & Alcohol Studies
Herausgeber: Wolff, Kim; Karch, Steven; White, Jason
The SAGE Handbook of Drug & Alcohol Studies
Herausgeber: Wolff, Kim; Karch, Steven; White, Jason
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This handbook explores the biological basis of drug and alcohol use, considering a wide scope of topics from the scientific determination of substance misuse, pharmacokinetics and pharmacodynamics, mechanisms of intoxication, overdose and death; as well as new approaches and controversies such as new types of addictions, decriminalisation, cultural influences and new information on neurobiology.
Andere Kunden interessierten sich auch für
Psychobiological Issues in Substance Use and Misuse52,99 €
Profiles of Drug Substances, Excipients, and Related Methodology158,99 €
The Journey from Prison to Community37,99 €
Amitava DasguptaFighting the Opioid Epidemic95,99 €
Donnellan - Fernandez, Roslyn, PhD, RM, RN, IBCLC MNg (Women's HealtPharmacology in Midwifery69,99 €
Daniel FringsThe Handbook of Alcohol Use143,99 €
Kathleen GlasgowYou'd Be Home Now14,99 €-
-
-
This handbook explores the biological basis of drug and alcohol use, considering a wide scope of topics from the scientific determination of substance misuse, pharmacokinetics and pharmacodynamics, mechanisms of intoxication, overdose and death; as well as new approaches and controversies such as new types of addictions, decriminalisation, cultural influences and new information on neurobiology.
Produktdetails
- Produktdetails
- Verlag: SAGE Publications Ltd
- Seitenzahl: 580
- Erscheinungstermin: 18. Oktober 2016
- Englisch
- Abmessung: 250mm x 175mm x 35mm
- Gewicht: 1178g
- ISBN-13: 9781446298671
- ISBN-10: 1446298671
- Artikelnr.: 40448390
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: SAGE Publications Ltd
- Seitenzahl: 580
- Erscheinungstermin: 18. Oktober 2016
- Englisch
- Abmessung: 250mm x 175mm x 35mm
- Gewicht: 1178g
- ISBN-13: 9781446298671
- ISBN-10: 1446298671
- Artikelnr.: 40448390
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Part I: Determination of Substance Misuse
1. Genetics and genomics in addiction research - Rohit Jaibhagwan Lodhi,
David Rossolatos and Katherine Jean Aitchison
2. Basic Pharmacokinetics of Substance Misuse - Kim Wolff
3. Future Directions: The role of pharmacogenomics - Jason White & Andrew
A. Somogyi
Part II: PK and PD in Relation to Patterns of Use
4. Alcohol: Pharmacokinetics and Pharmacodynamics - Matthew Goldin and E.
Jane Marshall
5. Nicotine: The Pharmacokinetics of Nicotine and Cotinine - Noorzurani
Robson
6. Opioids: A Discussion of Pharmacokinetics and Pharmacodynamics in Those
Who Misuse Drugs - Verena Metz & Sandy Corner
7. Cocaine: pharmacokinetics, pharmacodynamics and addictive potential -
Glenn Dumont
8. Amphetamine & Methamphetamine: Pharmacokinetics and Pharmacodynamics -
Kim P.C. Kuypers, Eef Theunissen and Jan Ramaekers
9. MDMA: Pharmacokinetics - Magí Farré, Esther Papaseit & Rafael de la
Torre
10. Benzodiazepines: A discussion of pharmacokinetic and pharmacodynamic
effects in those who misuse the drug - Alyson Bond & Malcolm Lader
11. Ketamine: the pharmacokinetics and pharmacodynamics in medicinal and
misusing populations - Kim Wolff
12. Cannabis: The pharmacokinetics and pharmacodynamics of recreational and
medicinal cannabis - Dave Allsop, Richard Kevin & Jonathon Arnold
13. Synthetic cannabinoids: The pharmacokinetics and pharmacodynamics of
'Spice' and other synthetic cannabinoids - Deepak D¿Souza & Aarti Gupta
14. Khat, Methedrone and MDPV: A discussion of pharmacokinetic and
pharmacodynamic parameters - Lorenza Colzato & Manuel Ruiz
15. Gamma-hydroxybutyric Acid (GHB): A discussion of pharmacokinetic and
pharmacodynamic effects of GHB including its analogues - John B. Saunders,
Jason Connor & Gerald Feeney
16. Polysubstance Use - Jason Connor, John Saunders, Adrian Kelly, Gerald
Feeney
Part III: Detection and Treatment of Drug and Alcohol Use
17. A brief overview of the detection of drug and alcohol use: the matching
of purposes and procedures. - Kim Wolff & Michael Gossop
18. Biomarkers of alcohol misuse - Natalie E Walsham & Roy A Sherwood
19. Treatment of Opioid Dependence - Kim Wolff, Steven Karch, Jason White
20. Wastewater Analysis for the Measurement of Population Level Drug Use:
Sewage-Based Epidemiology - Bram Miserez & Alexander van Nujs
Part IV: Special Settings
21. Forensic toxicology and death investigation - A Robert Forrest
22. Alcohol-related offences, alcohol use disorders and the workplace - Kim
Wolff, Samantha Gross, Noor Zurani-Robson and Jane Marshall
23. Future directions: What is the way forward for toxicology and forensic
research? - Steven B Karch
Part V: Controversies and New Approaches
24. Intravenous abuse of methylphenidate - Bjarni O. Rafnar and Gudrun Dora
Bjarnadottir
25. Non addictive drug use: The way forward - Christian P. Müller
26. Different Approaches to setting limits for drugs and alcohol use when
driving - Kim Wolff
27. Where do gambling and internet 'addictions' belong? The status of
'other' addictions - Mark D. Griffiths, Daria J. Kuss, Halley M. Pontes and
Joël Billieux
28. Emerging Tobacco Trends from the Arabian Cultures (Waterpipe and
Dokha): Global Prevalence, Health Risks and Propensity for Abuse - Annie
Crookes
29 Treating Benzodiazepine Dependence - abstinence or maintenance? -
Deborah Zador
30. ADHD: pathways into addiction, diagnosis and pharmacotherapy -
Pieter-Jan Carpentier, Philip Asherson & Ulrich Muller
31. Exploratory models to explain attention deficit hyperactivity disorder
and its association with substance use - Susan Young and Ottilie Sedgwick
1. Genetics and genomics in addiction research - Rohit Jaibhagwan Lodhi,
David Rossolatos and Katherine Jean Aitchison
2. Basic Pharmacokinetics of Substance Misuse - Kim Wolff
3. Future Directions: The role of pharmacogenomics - Jason White & Andrew
A. Somogyi
Part II: PK and PD in Relation to Patterns of Use
4. Alcohol: Pharmacokinetics and Pharmacodynamics - Matthew Goldin and E.
Jane Marshall
5. Nicotine: The Pharmacokinetics of Nicotine and Cotinine - Noorzurani
Robson
6. Opioids: A Discussion of Pharmacokinetics and Pharmacodynamics in Those
Who Misuse Drugs - Verena Metz & Sandy Corner
7. Cocaine: pharmacokinetics, pharmacodynamics and addictive potential -
Glenn Dumont
8. Amphetamine & Methamphetamine: Pharmacokinetics and Pharmacodynamics -
Kim P.C. Kuypers, Eef Theunissen and Jan Ramaekers
9. MDMA: Pharmacokinetics - Magí Farré, Esther Papaseit & Rafael de la
Torre
10. Benzodiazepines: A discussion of pharmacokinetic and pharmacodynamic
effects in those who misuse the drug - Alyson Bond & Malcolm Lader
11. Ketamine: the pharmacokinetics and pharmacodynamics in medicinal and
misusing populations - Kim Wolff
12. Cannabis: The pharmacokinetics and pharmacodynamics of recreational and
medicinal cannabis - Dave Allsop, Richard Kevin & Jonathon Arnold
13. Synthetic cannabinoids: The pharmacokinetics and pharmacodynamics of
'Spice' and other synthetic cannabinoids - Deepak D¿Souza & Aarti Gupta
14. Khat, Methedrone and MDPV: A discussion of pharmacokinetic and
pharmacodynamic parameters - Lorenza Colzato & Manuel Ruiz
15. Gamma-hydroxybutyric Acid (GHB): A discussion of pharmacokinetic and
pharmacodynamic effects of GHB including its analogues - John B. Saunders,
Jason Connor & Gerald Feeney
16. Polysubstance Use - Jason Connor, John Saunders, Adrian Kelly, Gerald
Feeney
Part III: Detection and Treatment of Drug and Alcohol Use
17. A brief overview of the detection of drug and alcohol use: the matching
of purposes and procedures. - Kim Wolff & Michael Gossop
18. Biomarkers of alcohol misuse - Natalie E Walsham & Roy A Sherwood
19. Treatment of Opioid Dependence - Kim Wolff, Steven Karch, Jason White
20. Wastewater Analysis for the Measurement of Population Level Drug Use:
Sewage-Based Epidemiology - Bram Miserez & Alexander van Nujs
Part IV: Special Settings
21. Forensic toxicology and death investigation - A Robert Forrest
22. Alcohol-related offences, alcohol use disorders and the workplace - Kim
Wolff, Samantha Gross, Noor Zurani-Robson and Jane Marshall
23. Future directions: What is the way forward for toxicology and forensic
research? - Steven B Karch
Part V: Controversies and New Approaches
24. Intravenous abuse of methylphenidate - Bjarni O. Rafnar and Gudrun Dora
Bjarnadottir
25. Non addictive drug use: The way forward - Christian P. Müller
26. Different Approaches to setting limits for drugs and alcohol use when
driving - Kim Wolff
27. Where do gambling and internet 'addictions' belong? The status of
'other' addictions - Mark D. Griffiths, Daria J. Kuss, Halley M. Pontes and
Joël Billieux
28. Emerging Tobacco Trends from the Arabian Cultures (Waterpipe and
Dokha): Global Prevalence, Health Risks and Propensity for Abuse - Annie
Crookes
29 Treating Benzodiazepine Dependence - abstinence or maintenance? -
Deborah Zador
30. ADHD: pathways into addiction, diagnosis and pharmacotherapy -
Pieter-Jan Carpentier, Philip Asherson & Ulrich Muller
31. Exploratory models to explain attention deficit hyperactivity disorder
and its association with substance use - Susan Young and Ottilie Sedgwick
Part I: Determination of Substance Misuse
1. Genetics and genomics in addiction research - Rohit Jaibhagwan Lodhi,
David Rossolatos and Katherine Jean Aitchison
2. Basic Pharmacokinetics of Substance Misuse - Kim Wolff
3. Future Directions: The role of pharmacogenomics - Jason White & Andrew
A. Somogyi
Part II: PK and PD in Relation to Patterns of Use
4. Alcohol: Pharmacokinetics and Pharmacodynamics - Matthew Goldin and E.
Jane Marshall
5. Nicotine: The Pharmacokinetics of Nicotine and Cotinine - Noorzurani
Robson
6. Opioids: A Discussion of Pharmacokinetics and Pharmacodynamics in Those
Who Misuse Drugs - Verena Metz & Sandy Corner
7. Cocaine: pharmacokinetics, pharmacodynamics and addictive potential -
Glenn Dumont
8. Amphetamine & Methamphetamine: Pharmacokinetics and Pharmacodynamics -
Kim P.C. Kuypers, Eef Theunissen and Jan Ramaekers
9. MDMA: Pharmacokinetics - Magí Farré, Esther Papaseit & Rafael de la
Torre
10. Benzodiazepines: A discussion of pharmacokinetic and pharmacodynamic
effects in those who misuse the drug - Alyson Bond & Malcolm Lader
11. Ketamine: the pharmacokinetics and pharmacodynamics in medicinal and
misusing populations - Kim Wolff
12. Cannabis: The pharmacokinetics and pharmacodynamics of recreational and
medicinal cannabis - Dave Allsop, Richard Kevin & Jonathon Arnold
13. Synthetic cannabinoids: The pharmacokinetics and pharmacodynamics of
'Spice' and other synthetic cannabinoids - Deepak D¿Souza & Aarti Gupta
14. Khat, Methedrone and MDPV: A discussion of pharmacokinetic and
pharmacodynamic parameters - Lorenza Colzato & Manuel Ruiz
15. Gamma-hydroxybutyric Acid (GHB): A discussion of pharmacokinetic and
pharmacodynamic effects of GHB including its analogues - John B. Saunders,
Jason Connor & Gerald Feeney
16. Polysubstance Use - Jason Connor, John Saunders, Adrian Kelly, Gerald
Feeney
Part III: Detection and Treatment of Drug and Alcohol Use
17. A brief overview of the detection of drug and alcohol use: the matching
of purposes and procedures. - Kim Wolff & Michael Gossop
18. Biomarkers of alcohol misuse - Natalie E Walsham & Roy A Sherwood
19. Treatment of Opioid Dependence - Kim Wolff, Steven Karch, Jason White
20. Wastewater Analysis for the Measurement of Population Level Drug Use:
Sewage-Based Epidemiology - Bram Miserez & Alexander van Nujs
Part IV: Special Settings
21. Forensic toxicology and death investigation - A Robert Forrest
22. Alcohol-related offences, alcohol use disorders and the workplace - Kim
Wolff, Samantha Gross, Noor Zurani-Robson and Jane Marshall
23. Future directions: What is the way forward for toxicology and forensic
research? - Steven B Karch
Part V: Controversies and New Approaches
24. Intravenous abuse of methylphenidate - Bjarni O. Rafnar and Gudrun Dora
Bjarnadottir
25. Non addictive drug use: The way forward - Christian P. Müller
26. Different Approaches to setting limits for drugs and alcohol use when
driving - Kim Wolff
27. Where do gambling and internet 'addictions' belong? The status of
'other' addictions - Mark D. Griffiths, Daria J. Kuss, Halley M. Pontes and
Joël Billieux
28. Emerging Tobacco Trends from the Arabian Cultures (Waterpipe and
Dokha): Global Prevalence, Health Risks and Propensity for Abuse - Annie
Crookes
29 Treating Benzodiazepine Dependence - abstinence or maintenance? -
Deborah Zador
30. ADHD: pathways into addiction, diagnosis and pharmacotherapy -
Pieter-Jan Carpentier, Philip Asherson & Ulrich Muller
31. Exploratory models to explain attention deficit hyperactivity disorder
and its association with substance use - Susan Young and Ottilie Sedgwick
1. Genetics and genomics in addiction research - Rohit Jaibhagwan Lodhi,
David Rossolatos and Katherine Jean Aitchison
2. Basic Pharmacokinetics of Substance Misuse - Kim Wolff
3. Future Directions: The role of pharmacogenomics - Jason White & Andrew
A. Somogyi
Part II: PK and PD in Relation to Patterns of Use
4. Alcohol: Pharmacokinetics and Pharmacodynamics - Matthew Goldin and E.
Jane Marshall
5. Nicotine: The Pharmacokinetics of Nicotine and Cotinine - Noorzurani
Robson
6. Opioids: A Discussion of Pharmacokinetics and Pharmacodynamics in Those
Who Misuse Drugs - Verena Metz & Sandy Corner
7. Cocaine: pharmacokinetics, pharmacodynamics and addictive potential -
Glenn Dumont
8. Amphetamine & Methamphetamine: Pharmacokinetics and Pharmacodynamics -
Kim P.C. Kuypers, Eef Theunissen and Jan Ramaekers
9. MDMA: Pharmacokinetics - Magí Farré, Esther Papaseit & Rafael de la
Torre
10. Benzodiazepines: A discussion of pharmacokinetic and pharmacodynamic
effects in those who misuse the drug - Alyson Bond & Malcolm Lader
11. Ketamine: the pharmacokinetics and pharmacodynamics in medicinal and
misusing populations - Kim Wolff
12. Cannabis: The pharmacokinetics and pharmacodynamics of recreational and
medicinal cannabis - Dave Allsop, Richard Kevin & Jonathon Arnold
13. Synthetic cannabinoids: The pharmacokinetics and pharmacodynamics of
'Spice' and other synthetic cannabinoids - Deepak D¿Souza & Aarti Gupta
14. Khat, Methedrone and MDPV: A discussion of pharmacokinetic and
pharmacodynamic parameters - Lorenza Colzato & Manuel Ruiz
15. Gamma-hydroxybutyric Acid (GHB): A discussion of pharmacokinetic and
pharmacodynamic effects of GHB including its analogues - John B. Saunders,
Jason Connor & Gerald Feeney
16. Polysubstance Use - Jason Connor, John Saunders, Adrian Kelly, Gerald
Feeney
Part III: Detection and Treatment of Drug and Alcohol Use
17. A brief overview of the detection of drug and alcohol use: the matching
of purposes and procedures. - Kim Wolff & Michael Gossop
18. Biomarkers of alcohol misuse - Natalie E Walsham & Roy A Sherwood
19. Treatment of Opioid Dependence - Kim Wolff, Steven Karch, Jason White
20. Wastewater Analysis for the Measurement of Population Level Drug Use:
Sewage-Based Epidemiology - Bram Miserez & Alexander van Nujs
Part IV: Special Settings
21. Forensic toxicology and death investigation - A Robert Forrest
22. Alcohol-related offences, alcohol use disorders and the workplace - Kim
Wolff, Samantha Gross, Noor Zurani-Robson and Jane Marshall
23. Future directions: What is the way forward for toxicology and forensic
research? - Steven B Karch
Part V: Controversies and New Approaches
24. Intravenous abuse of methylphenidate - Bjarni O. Rafnar and Gudrun Dora
Bjarnadottir
25. Non addictive drug use: The way forward - Christian P. Müller
26. Different Approaches to setting limits for drugs and alcohol use when
driving - Kim Wolff
27. Where do gambling and internet 'addictions' belong? The status of
'other' addictions - Mark D. Griffiths, Daria J. Kuss, Halley M. Pontes and
Joël Billieux
28. Emerging Tobacco Trends from the Arabian Cultures (Waterpipe and
Dokha): Global Prevalence, Health Risks and Propensity for Abuse - Annie
Crookes
29 Treating Benzodiazepine Dependence - abstinence or maintenance? -
Deborah Zador
30. ADHD: pathways into addiction, diagnosis and pharmacotherapy -
Pieter-Jan Carpentier, Philip Asherson & Ulrich Muller
31. Exploratory models to explain attention deficit hyperactivity disorder
and its association with substance use - Susan Young and Ottilie Sedgwick







